Skip to content
10-K

Annual Report

Twist Bioscience Corporation TWST

0001581280-25-000025

← back to feed
Filed
Nov 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Nov 13, 2025 61.15M sh
Shares Diluted FY 2025 · Sep 30, 2025 59.81M sh
Shares Diluted FY 2025 · Sep 30, 2024 58.02M sh
Shares Diluted FY 2025 · Sep 30, 2023 56.89M sh
Capex FY 2025 · Sep 30, 2025 $28M
Capex FY 2025 · Sep 30, 2024 $5.08M
Capex FY 2025 · Sep 30, 2023 $27.78M
Operating Cash Flow FY 2025 · Sep 30, 2025 −$47.63M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$64.09M
Operating Cash Flow FY 2025 · Sep 30, 2023 −$142.47M
Short Term Investments FY 2025 · Sep 30, 2025 $49.39M
Short Term Investments FY 2025 · Sep 30, 2024 $50.08M
Cash And Equivalents FY 2025 · Sep 30, 2025 $183.05M
Cash And Equivalents FY 2025 · Sep 30, 2024 $226.32M
Stockholders Equity FY 2025 · Sep 30, 2025 $472.96M
Stockholders Equity FY 2025 · Sep 30, 2024 $472.69M
Stockholders Equity FY 2025 · Sep 30, 2023 $623.43M
Current Liabilities FY 2025 · Sep 30, 2025 $91.41M
Current Liabilities FY 2025 · Sep 30, 2024 $71.01M
Total Liabilities FY 2025 · Sep 30, 2025 $168.9M
Total Liabilities FY 2025 · Sep 30, 2024 $141.63M
Current Assets FY 2025 · Sep 30, 2025 $332.97M
Current Assets FY 2025 · Sep 30, 2024 $346.78M
Total Assets FY 2025 · Sep 30, 2025 $641.86M
Total Assets FY 2025 · Sep 30, 2024 $614.32M
Eps Diluted FY 2025 · Sep 30, 2025 −$1.30
Eps Diluted FY 2025 · Sep 30, 2024 −$3.60
Eps Diluted FY 2025 · Sep 30, 2023 −$3.60
Eps Basic FY 2025 · Sep 30, 2025 −$1.30
Eps Basic FY 2025 · Sep 30, 2024 −$3.60
Eps Basic FY 2025 · Sep 30, 2023 −$3.60
Sga Expense FY 2025 · Sep 30, 2025 $246.98M
Sga Expense FY 2025 · Sep 30, 2024 $218.4M
Sga Expense FY 2025 · Sep 30, 2023 $189.74M
Rd Expense FY 2025 · Sep 30, 2025 $80.29M
Rd Expense FY 2025 · Sep 30, 2024 $90.85M
Rd Expense FY 2025 · Sep 30, 2023 $106.89M
Net Income FY 2025 · Sep 30, 2025 −$77.67M
Net Income FY 2025 · Sep 30, 2024 −$208.73M
Net Income FY 2025 · Sep 30, 2023 −$204.62M
Operating Income FY 2025 · Sep 30, 2025 −$136.26M
Operating Income FY 2025 · Sep 30, 2024 −$220.83M
Operating Income FY 2025 · Sep 30, 2023 −$217.16M
Cost Of Revenue FY 2025 · Sep 30, 2025 $185.57M
Cost Of Revenue FY 2025 · Sep 30, 2024 $179.63M
Cost Of Revenue FY 2025 · Sep 30, 2023 $155.38M
Revenue FY 2025 · Sep 30, 2025 $376.57M
Revenue FY 2025 · Sep 30, 2024 $312.97M
Revenue FY 2025 · Sep 30, 2023 $245.11M